Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
46,611,235
-
Share change
-
+1,886,841
-
Total reported value
-
$3,597,430,281
-
Put/Call ratio
-
173%
-
Price per share
-
$77.18
-
Number of holders
-
313
-
Value change
-
+$167,666,485
-
Number of buys
-
168
-
Number of sells
-
109
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2017
As of 30 Jun 2017,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
313 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,611,235 shares.
The largest 10 holders included
CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, UBS Group AG, Quantitative Investment Management, LLC, WELLS FARGO & COMPANY/MN, and ASSETMARK, INC.
This page lists
313
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.